AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇲🇼
EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE in Malawi
6 products registered with PMRA — 0 active, 6 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| EMTRICITABINE/TDF 200MG/300MG TABLET TABLET | PMPB/PL132/81 | — | expired | 31 Mar 2025 |
| EMTRICITABINE/TENOFOVIR_DISOPROXIL_FUMARATE 200/300MG TABLET TABLET | PMPB/PL67/141 | — | expired | 31 Mar 2025 |
| EMTRICITABINE_TDF 200/300MG TABLET TABLET | PMPB/PL280/31 | — | expired | 31 Mar 2024 |
| EMTRICITABINE,TDF 200MG/300MG TABLET TABLET | PMPB/PL401/31 | — | expired | 31 Mar 2024 |
| TEVIR_EM 200/300MG TABLET TABLET | PMPB/PL67/119 | — | expired | 30 Jun 2017 |
| ADCO_EMTEVIR 200/300MG TABLET TABLET | PMPB/PL1/92 | — | expired | 30 Jun 2015 |
EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE — PMRA Registration Details
PMRA (Malawi) has 6 registered products containing EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.
Track EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.